ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryEysinsAsceneuron SA
Asceneuron SA Logo
Verified· 3 sources

Asceneuron SA

Summary

About the company

The core activity of Asceneuron SA is the development of innovative small molecules and Tau modifiers for the treatment of diseases, particularly in the area of the central nervous system (CNS). The company focuses on the early stages of drug development and conducts clinical trials to test the efficacy and safety of its active ingredients.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Development of oral therapeutics for neurodegenerative diseases
Development of oral therapeutics targeting the causes of neurodegenerative diseases, with a portfolio of small molecules in clinical development.
Development of O-GlcNAcase inhibitors (OGA)
Small-molecule O-GlcNAcase inhibitors, including ASN51 and ASN90, developed to slow protein aggregation and treat pathological proteins.
Development of treatments for Alzheimer's disease
Development of therapeutic candidates for Alzheimer's disease, with ASN51 advanced toward phase II clinical development.
Biomedical research on protein aggregation
Research on O-GlcNAc modification, toxic aggregates of tau and alpha-synuclein, and biomarkers related to drug development.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Press

Media

July 16, 2024Media
Asceneuron closes $100 million series C financing round
startupticker.ch
October 16, 2023Media
Industry leaders to take startups to new heights
startupticker.ch
January 21, 2019Media
Biotech startups strengthen their teams for the next steps
startupticker.ch

Knowledge

No knowledge articles yet

Once Asceneuron SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Asceneuron SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Asceneuron SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Asceneuron SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de Crassier 7
1262 Eysins

At a glance

Legal form
Corporation
UID
CHE-181.731.651
Founded
2012 · 14 years
Last commercial register change
January 9, 2026
Employees
11 to 20

Similar companies

NB
ND BioSciences SA
Epalinges
VS
Vandria SA
Epalinges
MG
Medifit Groupe SA
Lausanne
MM
Medifit MTC Sàrl
Lausanne